Affordable Access

Access to the full text

Individualized metabolomics: opportunities and challenges

Authors
  • Misra, Biswapriya1
  • 1 Wake Forest University School of Medicine, Medical Center Boulevard , (United States)
Type
Published Article
Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Publisher
Walter de Gruyter GmbH
Publication Date
Apr 05, 2019
Volume
58
Issue
6
Pages
939–947
Identifiers
DOI: 10.1515/cclm-2019-0130
Source
De Gruyter
Keywords
License
Yellow

Abstract

The goal of advancing science in health care is to provide high quality treatment and therapeutic opportunities to patients in need. This is especially true in precision medicine, wherein the ultimate goal is to link disease phenotypes to targeted treatments and novel therapeutics at the scale of an individual. With the advent of -omics technologies, such as genomics, proteomics, microbiome, among others, the metabolome is of wider and immediate interest for its important role in metabolic regulation. The metabolome, of course, comes with its own questions regarding technological challenges. In this opinion article, I attempt to interrogate some of the main challenges associated with individualized metabolomics, and available opportunities in the context of its clinical application. Some questions this article addresses and attempts to find answers for are: Can a personal metabolome (n = 1) be inexpensive, affordable and informative enough (i.e. provide predictive yet validated biomarkers) to represent the entirety of a population? How can a personal metabolome complement advances in other -omics areas and the use of monitoring devices, which occupy our personal space?

Report this publication

Statistics

Seen <100 times